Maurizio Martini
Citata da
Citata da
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme
R Pallini, L Ricci-Vitiani, GL Banna, M Signore, D Lombardi, M Todaro, ...
Clinical Cancer Research 14 (24), 8205-8212, 2008
Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis
M Martini, M Ciccarone, G Garganese, C Maggiore, A Evangelista, ...
International journal of cancer 102 (4), 398-406, 2002
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ...
Clinical Cancer Research 15 (13), 4415-4422, 2009
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
R Pallini, L Ricci‐Vitiani, N Montano, C Mollinari, M Biffoni, T Cenci, ...
Cancer 117 (1), 162-174, 2011
Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results
JK Willmann, L Bonomo, AC Testa, P Rinaldi, G Rindi, KS Valluru, ...
Journal of Clinical Oncology 35 (19), 2133, 2017
Expression of EGFRvIII in glioblastoma: prognostic significance revisited
N Montano, T Cenci, M Martini, QG D’Alessandris, F Pelacchi, ...
Neoplasia 13 (12), 1113-IN6, 2011
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia
L Teofili, F Giona, M Martini, T Cenci, F Guidi, L Torti, G Palumbo, ...
Journal of Clinical Oncology 25 (9), 1048-1053, 2007
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin’s lymphomas
A Cingolani, R Gastaldi, L Fassone, F Pierconti, ML Giancola, M Martini, ...
Journal of clinical oncology 18 (19), 3325-3330, 2000
Influence of La3+-doping on radiation hardness and thermoluminescence characteristics of PbWO4
S Baccaro, P Bohacek, B Borgia, A Cecilia, I Dafinei, M Diemoz, M Ishii, ...
Physica Status Solidi. A, Applied Research 160 (2), R5-R6, 1997
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S Hohaus, M Giachelia, G Massini, G Mansueto, B Vannata, V Bozzoli, ...
Annals of oncology 20 (8), 1408-1413, 2009
The viral load of Epstein–Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma
S Hohaus, R Santangelo, M Giachelia, B Vannata, G Massini, A Cuccaro, ...
Clinical Cancer Research 17 (9), 2885-2892, 2011
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ...
Blood 131 (22), 2413-2425, 2018
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
D Rossi, S Rasi, V Spina, M Fangazio, S Monti, M Greco, C Ciardullo, ...
British journal of haematology 158 (3), 426, 2012
Proceedings of the International School of Physics “Enrico Fermi”
M Martini, M Milazzo, M Piacentini
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
A Inno, M Di Salvatore, T Cenci, M Martini, A Orlandi, A Strippoli, ...
Clinical colorectal cancer 10 (4), 325-332, 2011
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior
F Pierconti, M Martini, F Pinto, T Cenci, S Capodimonti, A Calarco, ...
The Prostate 71 (3), 318-325, 2011
BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid…
ED Rossi, M Martini, S Capodimonti, CP Lombardi, A Pontecorvi, ...
Cancer cytopathology 121 (6), 291-297, 2013
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation
L Teofili, M Martini, T Cenci, G Petrucci, L Torti, S Storti, F Guidi, G Leone, ...
Blood, The Journal of the American Society of Hematology 110 (1), 354-359, 2007
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
F Giona, L Teofili, ML Moleti, M Martini, G Palumbo, A Amendola, ...
Blood, The Journal of the American Society of Hematology 119 (10), 2219-2227, 2012
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis
L Teofili, F Giona, L Torti, T Cenci, BM Ricerca, C Rumi, V Nunes, R Fo, ...
haematologica 95 (1), 65-70, 2010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20